A systematic review finds AML patients receiving anthracycline remission induction therapy face a significant heart failure ...

What Is Acute Myeloid Leukemia? Acute myeloid leukemia (AML) is a type of blood cancer. It starts in your bone marrow, the soft inner parts of bones. AML usually begins in cells that turn into white ...

Acute myeloid leukemia (AML) is a type of leukemia, a cancer of the blood and bone marrow. AML specifically affects the myeloid cells, which are immature white blood cells. It is one of the most ...

Health care providers now recognize that determining treatment intensity requires careful evaluation of multiple patient factors beyond chronological age, including physiologic function, social ...

Moleculin Biotech ( (MBRX)) just unveiled an announcement. Moleculin Biotech has revealed promising findings showcasing Annamycin’s potential to combat acute myeloid leukemia (AML) resistant to ...

Results of a recently published long-term follow-up of the ASAP trial, which was conducted at universities and clinics across ...

Ziftomenib showed significant efficacy in relapsed/refractory NPM1-mutant AML, achieving deep, durable responses in the KOMET-001 trial. The trial enrolled 92 patients, with 23% achieving complete ...